News NHSBSA releases latest Medicines Used in Mental Health data Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
Sales & Marketing Sponsored Partnering with NHS in a crisis: The role for industry There has never been a better opportunity for the pharmaceutical industry for new partnerships
Patients A glance back to Pharma Integrates, London 2022 – part ii Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022.
News NICE backs Alnylam's Amvuttra for rare form of amyloidosis Alnylam's gene-silencing drug Amvuttra has been recommended as a treatment for hereditary transthyretin-related (ATTR) amyloidosis by NICE, paving the way for the drug to be made available
News A glance back to Pharma Integrates 2022 – part i Run by Life Science Integrates, Pharma Integrates was in its eleventh year in 2022.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
